找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Heparanase; From Basic Research Israel Vlodavsky,Ralph D. Sanderson,Neta Ilan Book 2020 The Editor(s) (if applicable) and The Author(s), u

[復(fù)制鏈接]
樓主: Iridescent
21#
發(fā)表于 2025-3-25 05:36:06 | 只看該作者
22#
發(fā)表于 2025-3-25 11:20:05 | 只看該作者
G. Bendas,Lubor Borsig for the non-mathematician; little more than high-school algebra being required. Part III presents many practical examples of how PDQ can be applied. The PDQ manual has been relegated to an appendix in Part IV,978-3-642-43713-7978-3-642-22583-3
23#
發(fā)表于 2025-3-25 14:11:15 | 只看該作者
24#
發(fā)表于 2025-3-25 17:48:27 | 只看該作者
Bo Tang,Shiming Yang for the non-mathematician; little more than high-school algebra being required. Part III presents many practical examples of how PDQ can be applied. The PDQ manual has been relegated to an appendix in Part IV,978-3-642-43713-7978-3-642-22583-3
25#
發(fā)表于 2025-3-25 23:21:46 | 只看該作者
Anqi Xiong,Argyris Spyrou,Karin Forsberg-Nilsson for the non-mathematician; little more than high-school algebra being required. Part III presents many practical examples of how PDQ can be applied. The PDQ manual has been relegated to an appendix in Part IV,978-3-642-43713-7978-3-642-22583-3
26#
發(fā)表于 2025-3-26 00:42:15 | 只看該作者
Giuliana Cassinelli,Cinzia Lanzi for the non-mathematician; little more than high-school algebra being required. Part III presents many practical examples of how PDQ can be applied. The PDQ manual has been relegated to an appendix in Part IV,978-3-642-43713-7978-3-642-22583-3
27#
發(fā)表于 2025-3-26 07:49:03 | 只看該作者
for the non-mathematician; little more than high-school algebra being required. Part III presents many practical examples of how PDQ can be applied. The PDQ manual has been relegated to an appendix in Part IV,978-3-642-43713-7978-3-642-22583-3
28#
發(fā)表于 2025-3-26 11:38:26 | 只看該作者
0065-2598 umor initiation, growth, angiogenesis, metastasis, and chemoresistance, supporting the notion that Heparanase is an important contributor to the poor outcome of cancer patients and a validated target for therap978-3-030-34523-5978-3-030-34521-1Series ISSN 0065-2598 Series E-ISSN 2214-8019
29#
發(fā)表于 2025-3-26 15:10:15 | 只看該作者
30#
發(fā)表于 2025-3-26 20:45:08 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 02:56
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
彰化市| 泸西县| 镇坪县| 亳州市| 沂水县| 策勒县| 桦南县| 长泰县| 潮州市| 泸水县| 阆中市| 仁怀市| 天峻县| 田林县| 彩票| 中江县| 浦城县| 盐边县| 榕江县| 漠河县| 壶关县| 永靖县| 鹰潭市| 轮台县| 万源市| 应用必备| 库尔勒市| 永泰县| 肃北| 韩城市| 广饶县| 错那县| 突泉县| 阳江市| 永靖县| 专栏| 通化县| 郓城县| 宜昌市| 聂拉木县| 昂仁县|